Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFCILLIN\NAFCILLIN vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFCILLIN\NAFCILLIN vs NALMEFENE: Safety Overview

Metric NAFCILLIN\NAFCILLIN NALMEFENE
Total FAERS Reports 147 197
Deaths Reported 20 77
Death Rate 13.6% 39.1%
Hospitalizations 70 118
Average Patient Age 59.4 yrs 44.2 yrs
% Female Patients 33.6% 39.3%
FDA Approval Date N/A Apr 17, 1995
Manufacturer N/A Purdue Pharma L.P.
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued